In addition, the half-time of circTMTC1 after actinomycin D treatment in 5–8 F cells was much longer than that of TMTC1 mRNA (Fig. 1C), implying it was highly stable in NPC cells. The gene discussed is TMTC1; the disease is nasopharyngeal carcinoma.